baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BAYER/ DE000BAY0017 /

2025-05-07 11:39:51 AM	Chg. -1.1	Volume	Bid12:07:22 PM	Ask12:07:22 PM	Market Capitalization	Dividend Y.	P/E Ratio
102.4PLN	-1.08%	12 Turnover: 1,228.3	101.1Bid Size: 300	102.4Ask Size: 300	99.7 bill.PLN	-	-

GlobeNewswire 05-06 Cytokinetics Reports First Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire 05-06 Daré Bioscience to Host First Quarter 2025 Financial Results and Company Update Conference Call and ...

GlobeNewswire 04-25 Freight Technologies Integrates with Blue Yonder TMS Through Bayer to Optimize Supply Chain Efficien...

GlobeNewswire 04-16 BlueRock Therapeutics announces publication in Nature of 18-month data from Phase 1 clinical trial f...

GlobeNewswire 04-08 AskBio Elects Dr. Laura Sepp-Lorenzino Independent Member of Board of Directors

TeleTrader 03-24 Bayer plunges 6% after $2B Monsanto verdict

GlobeNewswire 03-07 AskBio Advances Gene Therapy Clinical Trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 with Dosin...

TeleTrader 03-05 Bayer jumps 4.7% on strong earnings report

TeleTrader 03-05 Bayer's sales in Q4 at €11.7 billion, down 1%

TeleTrader 03-03 Earnings preview: German giants and tech firms

GlobeNewswire 02-27 UPDATE - YourUpdateTV Speaks with Alanna Morris-Simon from Bayer to Discuss Key Risk Factors for Hea...

GlobeNewswire 02-24 YourUpdateTV Speaks with Alanna Morris-Simon from Bayer to Discuss Key Risk Factors for Heart Diseas...

GlobeNewswire 02-19 AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease inves...

GlobeNewswire 02-13 First Participant Randomized in AskBio European Phase 2 Gene Therapy Trial for Congestive Heart Fail...

TeleTrader 2024-11-12 Bayer dips 12%, hits 20-year low after earnings report

TeleTrader 2024-11-12 Bayer's sales in Q3 down 3.6% to €9.9 billion

TeleTrader 2024-08-16 Bayer jumps 10% after Roundup court win

GlobeNewswire 2024-08-02 Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting A...

GlobeNewswire 2024-07-11 AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational...

GlobeNewswire 2024-06-25 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial

GlobeNewswire 2024-05-30 Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines

GlobeNewswire 2024-05-30 BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...

GlobeNewswire 2024-05-29 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach

GlobeNewswire 2024-05-28 Pairwise and Bayer Expand CRISPR Leafy Greens Market through Licensing Agreement

TeleTrader 2024-05-14 Bayer's sales in Q1 at €13.7 billion, down 4.3%

We would appreciate your inputs about what would improve our service

BAYER/ DE000BAY0017 /

If you wish to receive reply to your feedback, please provide your email address.